Detalhe da pesquisa
1.
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.
Respir Res;
21(1): 139, 2020 Jun 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32503599
Mostrar mais
Texto completo
Documentos relacionados
2.
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.
Respir Res;
21(1): 131, 2020 May 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32471423
3.
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD.
NPJ Prim Care Respir Med;
31(1): 29, 2021 05 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34035312
4.
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.
Adv Ther;
37(9): 3775-3790, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32647911
5.
Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.
Adv Ther;
39(3): 1446, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35060093
6.
Diagnosing pleural tuberculosis.
Chest;
125(6): 2366; author reply 2366-7, 2004 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15189967
7.
Vitamin K family effects on bone growth.
Bone;
48(6): 1427; author reply 1428, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21421089